Aveanna Healthcare Holdings Inc. AVAH
12.41
0.03
0.24%
as of 25 Sep
- Market cap
- $2.7B
- P/E
- 9.5×
Follow AVAH
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
6.59 | 5.19 | 7.56 | 23.34 |
+8 more quarters Free account |
P/S ratio |
0.72 | 0.55 | 0.68 | 0.81 | |
P/FCF ratio |
11.79 | 10.70 | 14.04 | 22.46 | |
P/Operating CF |
23.06 | 317.77 | 33.44 | 55.82 | |
P/B ratio |
6.50 | 5.76 | 8.55 | 201.80 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.24 | 1.05 | 1.21 | 1.39 | |
EV/EBITDA |
10.50 | 8.62 | 10.10 | 11.94 | |
EV/Operating CF |
19.22 | 19.12 | 23.32 | 35.46 | |
EV/FCF |
20.41 | 20.55 | 24.78 | 38.48 | |
Quick Ratio |
1.07 | 1.34 | 1.20 | 1.13 | |
Current Ratio |
1.16 | 1.47 | 1.32 | 1.23 | |
Net Debt/EBITDA |
15.43 | 16.33 | 16.05 | 21.25 | |
Debt/Assets |
69.45% | 72.31% | 72.79% | 81.06% | |
Debt/Equity |
5.09 | 6.09 | 7.53 | 159.80 | |
Asset Turnover |
1.34 | 1.37 | 1.32 | 1.33 | |
Operating CF/Net income |
2.01 | 0.10 | 0.28 | 2.36 | |
Capex/Depreciation |
(0.15) | (0.53) | (0.24) | (0.23) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
14.48% | 14.78% | 14.74% | 15.34% | |
Intangible Assets out of Total Assets |
0.65 | 0.60 | 0.60 | 0.67 | |
Share Based Compensation of Revenue |
0.62% | 0.64% | 0.60% | 0.80% | |
Graham Net Nets |
(0.72) | (0.87) | (0.76) | (0.70) | |
Graham Number |
6.21 | 5.59 | 4.82 | 0.61 | |
Earnings Yield |
15.17% | 19.25% | 13.22% | 4.28% | |
Free Cash Flow Yield |
8.49% | 9.35% | 7.12% | 4.45% | |
Revenue per Share |
3.08 | 3.02 | 3.26 | 2.98 | |
Operating CF per Share |
0.37 | 0.02 | 0.24 | 0.16 | |
Capex per Share |
(0.01) | (0.02) | (0.01) | (0.01) | |
Free Cash Flow per Share |
0.37 | 0.00 | 0.23 | 0.15 | |
Cash per Share |
0.45 | 0.88 | 0.95 | 0.70 | |
Shareholders Equity per Share |
1.32 | 1.12 | 0.96 | 0.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.32 | 1.12 | 0.96 | 0.04 | |
Free Cash Flow |
79.64 | (0.21) | 47.77 | 31.18 | |
Working Capital |
66.77 | 184.87 | 135.78 | 92.91 | |
Capital Expenditures |
(1.29) | (4.56) | (1.95) | (2.02) | |
Net Current Asset Value |
(1,341.01) | (1,206.69) | (1,257.69) | (1,298.67) | |
EV/EBIT |
11.80 | 9.69 | 11.44 | 13.73 | |
Capex to Sales |
0.00 | 0.01 | 0.00 | 0.00 | |
Net Profit Margin |
6.01% | 6.43% | 26.98% | 2.26% | |
Price to Operating Income |
6.81 | 5.04 | 6.48 | 8.02 | |
| Other line items | |||||
Average Receivables |
330.81 | 320.47 | 296.89 | 297.88 | |
Average Payables |
39.50 | 32.42 | 34.20 | 34.51 | |
Average Assets |
1,938.67 | 1,841.39 | 1,837.89 | 1,727.31 | |
Average Common Equity |
137.64 | 69.96 | 35.46 | (73.63) |
Columns are period end dates